Sensyne announces new chief scientific officer

AI company Sensyne Health plc has appointed Dr David Ruau as chief scientific officer, a newly created role, with effect from 1 September 2021. He will lead the research effort at Sensyne aimed at applying ethical AI to the improvement of patient care and the discovery and development of new medicines. Ruau has experience with the application…

You must be a HM Subscriber to view this content.

Subscribe Now »